Assessing the future landscape in myeloid malignancies: Evolving insights on farnesyltransferase inhibitors: Introduction

Joseph D. Rosenblatt; Jacob M. Rowe

doi:10.1053/shem.2002.35976

Assessing the future landscape in myeloid malignancies: Evolving insights on farnesyltransferase inhibitors: Introduction

Joseph D. Rosenblatt, Jacob M. Rowe

Medicine

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1-3
Number of pages	3
Journal	Seminars in Hematology
Volume	39
Issue number	3 SUPPL. 2
DOIs	https://doi.org/10.1053/shem.2002.35976
State	Published - Jul 2002

ASJC Scopus subject areas

Hematology

Access to Document

10.1053/shem.2002.35976

Cite this

@article{11497f0638c448558f6d73c52fd36bc4,

title = "Assessing the future landscape in myeloid malignancies: Evolving insights on farnesyltransferase inhibitors: Introduction",

author = "Rosenblatt, {Joseph D.} and Rowe, {Jacob M.}",

year = "2002",

month = jul,

doi = "10.1053/shem.2002.35976",

language = "English (US)",

volume = "39",

pages = "1--3",

journal = "Seminars in Hematology",

issn = "0037-1963",

publisher = "W.B. Saunders Ltd",

number = "3 SUPPL. 2",

}

TY - JOUR

T1 - Assessing the future landscape in myeloid malignancies

T2 - Evolving insights on farnesyltransferase inhibitors: Introduction

AU - Rosenblatt, Joseph D.

AU - Rowe, Jacob M.

PY - 2002/7

Y1 - 2002/7

UR - http://www.scopus.com/inward/record.url?scp=0036655774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036655774&partnerID=8YFLogxK

U2 - 10.1053/shem.2002.35976

DO - 10.1053/shem.2002.35976

M3 - Editorial

AN - SCOPUS:0036655774

VL - 39

SP - 1

EP - 3

JO - Seminars in Hematology

JF - Seminars in Hematology

SN - 0037-1963

IS - 3 SUPPL. 2

ER -

Assessing the future landscape in myeloid malignancies: Evolving insights on farnesyltransferase inhibitors: Introduction

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this